KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Return on Assets (2021 - 2025)

Historic Return on Assets for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Q3 2025 value amounting to 0.53%.

  • Recursion Pharmaceuticals' Return on Assets fell 300.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.44% for FY2024, which is 400.0% up from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Return on Assets of 0.53% as of Q3 2025, which was down 300.0% from 0.5% recorded in Q2 2025.
  • In the past 5 years, Recursion Pharmaceuticals' Return on Assets registered a high of 0.21% during Q3 2021, and its lowest value of 0.58% during Q1 2024.
  • For the 5-year period, Recursion Pharmaceuticals' Return on Assets averaged around 0.41%, with its median value being 0.41% (2023).
  • As far as peak fluctuations go, Recursion Pharmaceuticals' Return on Assets plummeted by -2000bps in 2024, and later soared by 1700bps in 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Return on Assets (Quarter) stood at 0.29% in 2021, then fell by -30bps to 0.37% in 2022, then plummeted by -36bps to 0.51% in 2023, then increased by 17bps to 0.43% in 2024, then fell by -24bps to 0.53% in 2025.
  • Its Return on Assets stands at 0.53% for Q3 2025, versus 0.5% for Q2 2025 and 0.42% for Q1 2025.